Science Explorer Back to mapMap
Discussion

Psyadon Pharmaceuticals (United States)

Research works
36
▼ 94% vs 2018-21
Citations
554
15.2 per fractional work
Top-10% rate
9.6%
all institutions 10.0%
Open access
11%
world 40%
International
26%
world 18%

Not ranked overall: Psyadon Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Psyadon Pharmaceuticals (United States) work in?

In all years, 49% of research at Psyadon Pharmaceuticals (United States) is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Medicine (35%), Chemistry (8%). It does 2.5× the world's share of Life Sciences.

Life Sciences: 18 fractional works · 49.3% of its workBiochemistry, Genetics and Molecular Biology: 16 fractional works · 45.0% of its workMolecular Biology: 12 fractional works · 33.1% of its workBiotechnology: 1 fractional works · 3.8% of its workCancer Research: 1 fractional works · 3.2% of its workCell Biology: 1 fractional works · 2.4% of its workPhysiology: 1 fractional works · 2.3% of its workNeuroscience: 1 fractional works · 2.3% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.9% of its workBiological Psychiatry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.8% of its workPharmaceutical Science: 0 fractional works · 1.3% of its workToxicology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 0.2% of its workHealth Sciences: 14 fractional works · 37.1% of its workMedicine: 13 fractional works · 35.1% of its workOncology: 5 fractional works · 14.0% of its workInfectious Diseases: 2 fractional works · 5.3% of its workEpidemiology: 1 fractional works · 3.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.4% of its workDermatology: 1 fractional works · 1.8% of its workPharmacology: 0 fractional works · 1.2% of its workPathology and Forensic Medicine: 0 fractional works · 1.1% of its workSurgery: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.9% of its workRheumatology: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.5% of its workTransplantation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNursing: 1 fractional works · 1.8% of its workNutrition and Dietetics: 1 fractional works · 1.8% of its workHealth Professions: 0 fractional works · 0.2% of its workPhysical Sciences: 4 fractional works · 12.2% of its workChemistry: 3 fractional works · 7.9% of its workOrganic Chemistry: 2 fractional works · 5.7% of its workSpectroscopy: 0 fractional works · 1.2% of its workAnalytical Chemistry: 0 fractional works · 0.9% of its workEngineering: 1 fractional works · 1.8% of its workBiomedical Engineering: 1 fractional works · 1.8% of its workComputer Science: 0 fractional works · 0.9% of its workComputational Theory and Mathematics: 0 fractional works · 0.9% of its workEnvironmental Science: 0 fractional works · 0.9% of its workEcology: 0 fractional works · 0.9% of its workMaterials Science: 0 fractional works · 0.8% of its workBiomaterials: 0 fractional works · 0.5% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 1.3% of its workPsychology: 0 fractional works · 1.2% of its workClinical Psychology: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workALL ITS WORKPsyadonPharmaceuticals…36fractional works, all years
Life Sciences49%Physical Sciences12%Health Sciences37%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1645.0%
    2. Neuroscience12.3%
    3. Pharmacology, Toxicology and Pharmaceutics11.8%
    4. Immunology and Microbiology00.2%
    1. Medicine1335.1%
    2. Nursing11.8%
    3. Health Professions00.2%
    1. Chemistry37.9%
    2. Engineering11.8%
    3. Computer Science00.9%
    4. Environmental Science00.9%
    5. Materials Science00.8%
    1. Psychology01.2%
    2. Economics, Econometrics and Finance00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Psyadon Pharmaceuticals (United States)?

Ranked on the quality score, Ricardo Cibotti, Deog Joong Kim and Chang‐Ho Ahn lead among researchers whose main affiliation is Psyadon Pharmaceuticals (United States).

  1. 1 Ricardo Cibotti United States · #3,786,774 worldwide 21 citations · 33 works
  2. 2 Deog Joong Kim United States · #4,560,238 worldwide 461 citations · 30 works
  3. 3 Chang‐Ho Ahn United States · #5,332,615 worldwide 626 citations · 50 works
All ranked researchers at Psyadon Pharmaceuticals (United States)

What are the most cited papers from Psyadon Pharmaceuticals (United States)?

The most cited paper from Psyadon Pharmaceuticals (United States) is "Targeted gene knockout mediated by triple helix forming oligonucleotides" (Alokes Majumdar, Alexander A. Khorlin, Natalia B. Dyatkina et al., 1998), with 149 citations. Next come "Identification of a Novel Mammary-Restricted Cytochrome P450, CYP4Z1, with Overexpression in Breast Carcinoma" (111) and "A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome" (106).

Most cited papers
#PaperReleasedCitations
1 Targeted gene knockout mediated by triple helix forming oligonucleotides Alokes Majumdar, Alexander A. Khorlin, Natalia B. Dyatkina et al. · Nature Genetics Oct 1998 149
2 Identification of a Novel Mammary-Restricted Cytochrome P450, CYP4Z1, with Overexpression in Breast Carcinoma Michael A. Rieger, Reinhard Ebner, David Bell et al. · Cancer Research Apr 2004 111
3 A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome Donald L. Gilbert, Cathy L. Budman, Harvey S. Singer et al. · Clinical Neuropharmacology 2014 106
4 Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study Donald L. Gilbert, Tanya K. Murphy, Joseph Jankovic et al. · Movement Disorders Aug 2018 85
5 Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity Won Jun Choi, Hwa‐Jin Chung, Girish Chandra et al. · Journal of Medicinal Chemistry 23 Apr 2012 71
All 45 most cited papers, with filters and sorting

Which keywords describe research at Psyadon Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, Therapeutic Targets, Regulation, Cancer Therapy, Antiretroviral Therapy, Cancer Progression and Enzyme Regulation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Immunotherapy3▲ 14×8 topics
  2. Tumor Microenvironment3▲ 25×6 topics
  3. Therapeutic Targets3▲ 32×4 topics
  4. Regulation3▲ 12×2 topics
  5. Antiretroviral Therapy2▲ 30×2 topics
  6. Cancer Progression2▲ 30×2 topics
  7. Cancer Therapy2▲ 11×4 topics
  8. Enzyme Regulation2▲ 140×1 topic
  9. Nucleotide Metabolism2▲ 194×1 topic
  10. RNA methylation2▲ 85×1 topic
  11. m6A-seq2▲ 85×1 topic
  12. Drug Resistance2▲ 21×3 topics
  13. Apoptosis2▲ 16×3 topics
  14. Chemotherapy2▲ 8.2×7 topics
  15. Gene Therapy2▲ 21×2 topics
  16. Tumor Targeting2▲ 43×3 topics
  17. Cell Cycle2▲ 96×2 topics
  18. MDM22▲ 125×1 topic
  19. Tumor Suppression2▲ 48×2 topics
  20. p532▲ 125×1 topic
  21. HIV Infection2▲ 43×1 topic
  22. Integrase Inhibitors2▲ 128×1 topic
  23. Medicinal Chemistry2▲ 14×7 topics
  24. Nanoparticles2▲ 4.0×4 topics
  25. Genomic Stability2▲ 52×2 topics
  26. DNA Structure2▲ 68×1 topic
  27. G-Quadruplexes2▲ 68×1 topic
  28. Arginine Deprivation1▲ 87×1 topic
  29. Bacterial Therapy1▲ 87×1 topic
  30. Drug Discovery1▲ 8.7×4 topics
  31. Oxidative Stress1▲ 1.97×6 topics
  32. Synthesis1▲ 5.7×6 topics
  33. Biological Evaluation1▲ 24×4 topics
  34. Cancer1▲ 2.1×7 topics
  35. Epidemiology1▼ 0.74×6 topics
  36. Inflammation1▲ 1.30×3 topics
  37. Treatment1▲ 2.4×3 topics
  38. DNA Damage1▲ 21×2 topics

Which research topics does Psyadon Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Renal Diseases and Glomerulopathies, Organ Transplantation Techniques and Outcomes, Healthcare Policy and Management and Emergency and Acute Care Studies.

  1. 1 Renal Diseases and Glomerulopathies Nephrology 0 works
  2. 2 Organ Transplantation Techniques and Outcomes Surgery 0 works
  3. 3 Healthcare Policy and Management Economics and Econometrics 0 works
  4. 4 Emergency and Acute Care Studies Emergency Medicine 0 works
  5. 5 Renal Transplantation Outcomes and Treatments Transplantation 0 works
  6. 6 Xenotransplantation and immune response Surgery 0 works
  7. 7 Pancreatic function and diabetes Surgery 0 works
  8. 8 Transplantation: Methods and Outcomes Surgery 0 works
  9. 9 T-cell and B-cell Immunology Immunology 0 works
  10. 10 Diabetes and associated disorders Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available11.2%not open88.8%

World: 40% of research is openly available.

with international co-authors25.6%domestic only74.4%

World: 18% is written across borders.

How has Psyadon Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 94% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Psyadon Pharmaceuticals (United States) as a percentage of every work published that year, 0.0000037% in 2023.

still counting0.00020%0.00040%Psyadon Pharmaceuticals (United States)0.0000029% in 2025200020102020

Fractional works of Psyadon Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Germantown

All research institutions in Germantown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Psyadon Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.